U.S. flag

An official website of the United States government

Display Settings:

Format
Sort by

Send to:

Choose Destination

Links from Nucleotide

Items: 4

1.
PharmGKB summary: very important pharmacogene information for CYP3A5
Jatinder Lamba, Joan M. Hebert, Erin G. Schuetz, Teri E. Klein, Russ B. Altman
Pharmacogenet Genomics. Author manuscript; available in PMC 2013 Aug 8.
Published in final edited form as: Pharmacogenet Genomics. 2012 Jul; 22(7): 555–558. doi: 10.1097/FPC.0b013e328351d47f
PMCID:
PMC3738061
ArticlePDF–39K
2.
Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects
Ji H Choi, Yoon J Lee, Seong B Jang, Jong-Eun Lee, Kyung H Kim, Kyungsoo Park
Br J Clin Pharmacol. 2007 Aug; 64(2): 185–191. Published online 2007 Mar 28. doi: 10.1111/j.1365-2125.2007.02874.x
PMCID:
PMC1974827
AbstractArticlePDF–145K
3.
CYP3A5 phenotype-genotype correlations in a British population
Barry P King, Julian B S Leathart, Elaine Mutch, Faith M Williams, Ann K Daly
Br J Clin Pharmacol. 2003 Jun; 55(6): 625–629. doi: 10.1046/j.1365-2125.2003.01798.x
Correction in:
Br J Clin Pharmacol. 2004 May; 57(5): 644.
PMCID:
PMC1884247
AbstractArticlePDF–118K
4.
CYP3A Variation and the Evolution of Salt-Sensitivity Variants
E. E. Thompson, H. Kuttab-Boulos, D. Witonsky, L. Yang, B. A. Roe, A. Di Rienzo
Am J Hum Genet. 2004 Dec; 75(6): 1059–1069. Published online 2004 Oct 18. doi: 10.1086/426406
PMCID:
PMC1182141
AbstractArticlePDF–484K

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center